Reply  by Gibson, Kathleen
number of perforating veins to be found and treated in these “mild”
classes. Were they really just branch veins?
The authors provide no information on where they accessed
the SSV and how much was ablated, a point of debate in en-
dovenous SSV treatment. The observation regarding the frequent
relationship of the SSV to the intersaphenous vein, either as an
extension or a direct continuation in 57% of the limbs, is a unique
anatomic finding. I am curious, however, why no other incompe-
tent veins of the popliteal fossa, such as the gastrocnemius or
popliteal area veins, which are not accessible to their technique,
were not detected in such a large series. These other veins of the
popliteal fossa may, if incompetent, perpetuate reflux in the pop-
liteal fossa, even if the SSV is treated properly. For example, Gillet
et al5 reported a 20% incidence of incompetent gastrocnemius
veins in a series of 180 operations for SSV incompetence, a pro-
portion similar to that described by Hobbs and Vandendriessche.6
The 5.7% incidence of deep venous thrombosis is troubling,
particularly when compared with results with endovenous laser
treatment of the great saphenous vein or open surgical series.
Moreover, the incidence is actually higher in this series, when the
patients with type C anatomy (no direct termination of the SSV in
the popliteal vein) are eliminated. In these patients there is no
chance of thermal energy from the laser tip directly damaging the
popliteal vein. When the incidence of deep vein thrombosis is
calculated on this basis, the incidence for at risk patients was
actually 12%. This may be too high a price to pay for this less
invasive approach to the SSV.
Thomas F. O’Donnell, Jr, MD
The Vein Center
Tufts-New England Medical Center
Boston, Mass
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Reply
We thankDrO’Donnell for his comments and agree that report-
ing standards and current anatomic terminology are important. The
paper was submitted as “Endovenous Laser Treatment of the Small
Saphenous Vein: Efficacy and Complications,” but the anatomic
terminology was changed by the JVS proofreaders in error to “short
saphenous vein.” A correction has been issued by JVS.
The purpose of our series was to show that EVLT of the small
saphenous vein (SSV) was feasible and to determine the rate of
complications. We defined efficacy as duplex-proven closure of the
SSV and elimination of reflux. DrO’Donnell alludes in his comments
to the reason that we did not include the Venous Clinical Severity
Score as a measure of efficacy. Because fully 78% of limbs underwent
concomitant EVLT of the great saphenous vein, it would be impos-
sible to tease out what the benefit of the SSV ablation was specifically
in terms of any change in the Venous Clinical Severity Score. Instead,
we defined efficacy very objectively, as stated above.
Dr O’Donnell is correct in noting that only the CEAP clinical
classification is noted in the article. In the article and the accom-
panying table, we did call this “CEAP clinical classification” and
not just “CEAP classification.” Dr O’Donnell is also correct in
assuming that all limbs had reflux.
Because the paper had to be edited to meet the length require-
ments of JVS, a number of procedural details and details regarding
concomitant procedures (great saphenous vein EVLT, perforator
ligation, and microphlebectomy) were not outlined. In our vascular
laboratory, we define reflux by valve closure time greater than
2 seconds.Mean andmedian valve closure times were not collected in
the data for the study. SSVs were treated only if they demonstrated
reflux and were causing clinical symptoms or were cosmetically both-
ersome varicose veins. Criteria for perforator incompetence included
both reflux anddiameter. Perforator veinswere treatedonly if deemed
to be either clinically or cosmetically significant: ie, if they were
tributaries into clusters of varicosities that either were symptomatic or
bothered the patient from a cosmetic standpoint. Although other
authors have found that routine perforator ligation is unnecessary in
treating patients without deep venous insufficiency in terms of im-
provement in APG-measured hemodynamic parameters and clinical
symptom score,1 in our practice we have had suboptimal cosmetic
results when we have left perforator veins to clusters of varicosities
remote from the SSV or great saphenous vein untreated.
The length of SSV treated and the access point were left to the
discretion of the treating surgeon (three surgeons were involved in
the study). In general, the ablation was started 1.5 to 2.0 cm from
the saphenopopliteal junction (SPJ) if no intersaphenous vein was
present and just distal to the intersaphenous vein if it was present.
Access was obtained in some cases as low as just above the lateral
malleolus. We noted no difference in the incidence of paresthesias
in patients with “low” access. Incompetent popliteal fossa veins
other than the intersaphenous vein were not specifically tracked,
but if present and causing clusters of varicosities untreated by
EVLT, they were addressed by microphlebectomy of the branches.
We agree that a 5.7% incidence of deep venous thrombosis
(DVT) is high (the incidence was 11.4% for type A anatomy, 2.9% for
type B anatomy, and 0% for type C anatomy); however, we believe
that our definition of DVT was very conservative. Any extension of
clot into the SPJ was defined as aDVT.Wewould now describe these
clots as endovenous heat-induced thrombosis (EHIT; as described by
Kabnick et al2).We agreewithKabnick and colleagues that EHITs do
not behave like de novo DVTs. Kabnick and associates’ abstract
suggested that clots flush with the saphenofemoral junction or SPJ
do not need anticoagulation and recommended that clots extend-
ing into the saphenofemoral junction or SPJ filling less than 50% of
the diameter of the deep vein be treated with low-molecular-
weight heparin until the thrombus recedes out of the deep vein.
Clots filling greater than 50% of the diameter of the deep vein or
occlusive clots are treated with standard DVT treatments. Accord-
ing to these criteria, none of the limbs in our study with “DVT”
would require standardDVT treatment, as all filled less than 50% of
the popliteal lumen. Since completing this study, we treat our
patients with EHIT with the above algorithm, and all have uni-
formly showed resolution of the EHIT within a matter of days
without any bleeding or thrombotic complication. We believe that
EVLT of the SSV offers patients a significantly easier recovery with
reduced morbidity compared with stripping of the SSV. As EHITs
have had a benign course in all of our patients both during and
since our study and as the incidence of nerve injury is very low,
EVLT of the SSV is the procedure of choice in patients with SSV
incompetence in our practice.
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Regarding “Endovenous laser treatment of the short
saphenous vein: Efficacy and complications”
I enjoyed the excellent article of Gibson et al,1 and have a
question about the details of endovenous laser treatment (EVLT)
with respect to the Giacomini vein termination. The recurrence
rate of the small saphenous vein (SSV) is generally more than 30%.2
The point where the Giacomini vein connects to the SSV differs
among individual patients, ranging from immediately subfascial
(Fig, B) to deep near the saphenopopliteal junction (SPJ; Fig A).3
By using EVLT beginning distal to the termination of the Giaco-
mini vein, in order to preserve flow from the Giacomini vein to the
SSV in type B patients, a long SSV stump is left, which might cause
treatment failure and recurrence. Do the authors always start
EVLT from distal to the termination of the Giacomini vein when
treating type B patients? How do they perform EVLT in patients
with reflux in both the SSV trunk and Giacomini vein?
We prefer to start EVLT from 1 cm to 1.5 cm distal to the SPJ
to avoid leaving a long residual SSV stump. Therefore, for almost
all patients, we conduct EVLT proximal to the site where the
Giacomini vein is drained. Contrary to the variability of the Gia-
comini vein termination, in case of the gastrocnemius vein termi-
nating at the SSV, it terminated almost always just distal of the SPJ.
Thus, we start EVLT from 1 to 1.5 cm distal to the site where the
gastrocnemius vein terminated into the SSV to maintain the nor-
mal venous flow of the gastrocnemius vein.
Our clinical experience with more than 4600 limbs (including
1086 SSVs) treated with EVLT spans 5 years, with all patients
undergoing post-EVLT duplex scans at multiple time periods. Our
routine follow-up duplex scan schedule is 2 days, 1 week, 1 month,
3 months, 6 months, thereafter annually. Surprisingly, we have
never seen a deep vein thrombosis in any of our patients.
Seung Joon Park, MD
Su Bin Yim, MD
Dae Won Cha, MD
Sung Chul Kim, MD
Department of Phlebology
Samsung Vein Surgery Clinic
Korea
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Regarding “Duplex surveillance following carotid
surgery: effect of management policy”
I refer to the study by Ballotta and colleagues, which described
the outcome of 599 patients following carotid endarterectomy.1 The
authors report excellent perioperative results and also examine
the outcome of follow-up duplex surveillance. The authors
conclude that their findings strongly support the value of duplex
surveillance every 6 months after carotid surgery. The interpreta-
tion of this study needs to take into account controversies regard-
ing managing asymptomatic carotid artery disease.2,3 An imaging
finding is primarily of value if it alters the clinical management of
the patient. The potential findings from surveillance after carotid
surgery include ipsilateral restenosis or contralateral progression of
stenosis. While this and other studies indicate that both these
problems can be easily and commonly identified by duplex surveil-
lance, the management of them remains controversial.4 Ipsilateral
restenosis particularly, if developing within the first year following
surgery, is believed to have a benign natural history and, therefore,
many clinicians treat such lesions medically.4 Similarly, the man-
agement of asymptomatic carotid stenosis also remains controver-
sial with meta-analyses suggesting significant but small reduction
in stroke incidence based on interventional treatment of all patients
with asymptomatic carotid stenosis.2,3 Only two of the patients in
the present study suffered a stroke associated with progression of
Endovenous laser therapy of small saphenous vein (SSV). A, The
Giacomini vein connects to the SSV near saphenopopliteal junc-
tion. B, The Giacomini vein connects to the SSV at immediate
subfascial level, leaving a long stump. PV, Popliteal vein; SF,
superficial fascia; DF, deep fascia.
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